Literature DB >> 2318216

Vancomycin-aminoglycoside combinations in therapy of endocarditis caused by Enterococcus species and Streptococcus bovis.

J M Besnier1, C Leport, A Buré, J L Vildé.   

Abstract

Between 1974 and 1986, five patients with enterococcal endocarditis (three of whom had a prosthetic valve) and three patients with Streptococcus bovis endocarditis were treated with a combination of vancomycin and an aminoglycoside for a mean duration of 40 days. This regimen was prescribed because of allergy to beta-lactam (n = 7) and/or failure of previous treatment (n = 4). Three of the eight patients underwent valve replacement. In the six evaluable patients cure was achieved with the vancomycin-aminoglycoside combination. An increase of the creatinine serum levels was observed in all cases but it was never necessary to discontinue treatment, adjustment of the vancomycin and aminoglycoside dosage according to the serum and/or serum creatinine levels allowing continuation of therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318216     DOI: 10.1007/bf01963638

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963-72.

Authors:  L L Pelletier; R G Petersdorf
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

2.  Vancomycin therapy for enterococcal and Streptococcus viridans endocarditis. Successful treatment of six patients.

Authors:  C K Friedberg; K M Rosen; P A Bienstock
Journal:  Arch Intern Med       Date:  1968-08

3.  Synergism of vancomycin and streptomycin for enterococci.

Authors:  G L Mandell; E Lindsey; E W Hook
Journal:  Am J Med Sci       Date:  1970-05       Impact factor: 2.378

4.  Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.

Authors:  C Watanakunakorn; C Glotzbecker
Journal:  J Med Microbiol       Date:  1977-02       Impact factor: 2.472

5.  Antimicrobial therapy of experimental enterococcal endocarditis.

Authors:  E W Hook; R B Roberts; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

6.  Fifty cases of late prosthetic valve endocarditis: improvement in prognosis over a 15 year period.

Authors:  C Leport; J L Vilde; F Bricaire; A Cohen; B Pangon; C Gaudebout; P E Valere
Journal:  Br Heart J       Date:  1987-07

7.  Vancomycin therapy of bacterial endocarditis.

Authors:  E W Hook; W D Johnson
Journal:  Am J Med       Date:  1978-09       Impact factor: 4.965

8.  High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections.

Authors:  L M Bush; J Calmon; C L Cherney; M Wendeler; P Pitsakis; J Poupard; M E Levison; C C Johnson
Journal:  Ann Intern Med       Date:  1989-04-01       Impact factor: 25.391

9.  Vancomycin therapy for infective endocarditis.

Authors:  J E Geraci; W R Wilson
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

10.  Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.

Authors:  B F Farber; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

View more
  2 in total

1.  Enterococcus faecalis endocarditis following percutaneous manipulation of a biliary tract calculus and ERCP.

Authors:  A R Ronald; A L Pattullo
Journal:  Can J Infect Dis       Date:  1990

2.  Patterns of antibiotic resistance among enterococcal strains isolated from clinical specimens and food in Poland.

Authors:  T Zareba; W Hryniewicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.